 |
|
 |
|
|
Cinolazepam
|
|
| Systematic (IUPAC) name | |
| 3-[9-chloro- 6-(2-fluorophenyl)- 4-hydroxy- 3-oxo- 2,5-diazabicyclo [5.4.0]undeca- 5,8,10,12- tetraen- 2-yl] propanenitrile | |
| Identifiers | |
| CAS number | |
| ATC code | N05 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C18H13ClFN3O2 |
| Mol. mass | 357.8 |
| Pharmacokinetic data | |
| Bioavailability | 90-100% |
| Metabolism | Hepatic |
| Half life | 9 h[1] |
| Excretion | Renal |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
Unscheduled(US) |
| Routes | Oral |
Cinolazepam (marketed under the brand name Gerodorm)[2] is a drug which is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. Due to its strong sedative properties, it is primarily used as an hypnotic.
Cinolazepam is not approved for sale in the United States or Canada.
See also
References
- ^ Saletu, B.; G. Kindshofer, P. Anderer, J. Grunberger (1987). "Short-term sleep laboratory studies with cinolazepam in situational insomnia induced by traffic noise.". International Journal of Clinical Pharmacology Research 7 (5): 407–18. PMID 2889679.
- ^ Lannacher Romania (1999). "Gerodorm" (in Romanian). Produse Gerot inregistrate in Romania. http://www.lannacher.ro/gerodorm.html. Retrieved on 17 August 2006.
External links
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
